TP53 and diabetes mellitus: More specifically, HBP administration influenced the expression of genes associated with diabetes, such as CDKN1A, CD68, C1qa, and C1qb, which are linked to signaling pathways involving Hippo, TGF-beta, HIF-1, p53, and cGMP-PKG.